Drug Type Small molecule drug |
Synonyms EVEGYN |
Target |
Action modulators |
Mechanism DNA modulators(DNA modulators), Ergosterol biosynthesis inhibitors, SCNA modulators(Sodium channel alpha subunit modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC8H13N3O4S |
InChIKeyHJLSLZFTEKNLFI-UHFFFAOYSA-N |
CAS Registry19387-91-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bacterial Vaginosis | Phase 3 | Turkey | 20 Jul 2020 | |
Candidiasis, Vulvovaginal | Phase 3 | Turkey | 20 Jul 2020 | |
Infective vaginitis | Phase 3 | Turkey | 20 Jul 2020 | |
Trichomonas Vaginitis | Phase 3 | Turkey | 20 Jul 2020 |